-
OLMESARTAN/ AMLODIPINE - MYL 20/5 olmesartan medoxomil 20 mg
Availability: Reduction in supply until supply is exhausted Deletion from market: 31 Jul 2024 -
OLMESARTAN/ AMLODIPINE - MYL 40/10 olmesartan medoxomil 40 mg
Availability: Reduction in supply until supply is exhausted Deletion from market: 30 Aug 2024 -
BIMTOP bimatoprost 300 microgram
Availability: Reduction in supply until supply is exhausted Deletion from market: 30 Jun 2024 -
View Detail
CERVAGEM gemeprost 1mg
Availability: Reduction in supply until supply is exhausted Deletion from market: 16 Jun 2025 -
View Detail
ORUDIS SR ketoprofen 200mg
Availability: Reduction in supply until supply is exhausted Deletion from market: 31 Dec 2024 -
View Detail
FIASP insulin aspart (rys) 100 units/mL solution for injection 10 mL
Availability: Reduction in supply until supply is exhausted Deletion from market: 01 Dec 2024 -
View Detail
FIASP FLEXTOUCH insulin aspart (rys) 100 units/mL solution for injection 3 mL
Availability: Reduction in supply until supply is exhausted Deletion from market: 01 Mar 2025 -
DBL BORTEZOMIB 2.5 mg
Availability: Reduction in supply until supply is exhausted Deletion from market: 01 Oct 2024 -
View Detail
RYZODEG 70/30 FLEXTOUCH 70% insulin degludec (rys) / 30% insulin aspart (rys) 100 U/mL solution for injection cartridge
Availability: Reduction in supply until supply is exhausted Deletion from market: 01 Feb 2025 -
BORTEZOMIB JUNO bortezomib 1mg
Availability: Reduction in supply until supply is exhausted Deletion from market: 01 Jul 2024 -
EPHEDRINE HYDROCHLORIDE JUNO ephedrine hydrochloride 30 mg/10 mL
Availability: Reduction in supply until supply is exhausted Deletion from market: 01 Sep 2024 -
BETASERT betahistine dihydrochloride 16 mg
Availability: Unavailable Deletion from market: 06 Aug 2024
